JP2014525448A5 - - Google Patents

Download PDF

Info

Publication number
JP2014525448A5
JP2014525448A5 JP2014528537A JP2014528537A JP2014525448A5 JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5 JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014528537 A JP2014528537 A JP 2014528537A JP 2014525448 A5 JP2014525448 A5 JP 2014525448A5
Authority
JP
Japan
Prior art keywords
imidazo
oxadiazol
pyridine
methyl
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014528537A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014525448A (ja
JP6134319B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/052802 external-priority patent/WO2013033167A1/en
Publication of JP2014525448A publication Critical patent/JP2014525448A/ja
Publication of JP2014525448A5 publication Critical patent/JP2014525448A5/ja
Application granted granted Critical
Publication of JP6134319B2 publication Critical patent/JP6134319B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014528537A 2011-09-01 2012-08-29 c−kitキナーゼインヒビターとしての化合物及び組成物 Active JP6134319B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161530038P 2011-09-01 2011-09-01
US61/530,038 2011-09-01
PCT/US2012/052802 WO2013033167A1 (en) 2011-09-01 2012-08-29 Compounds and compositions as c-kit kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2014525448A JP2014525448A (ja) 2014-09-29
JP2014525448A5 true JP2014525448A5 (https=) 2015-10-29
JP6134319B2 JP6134319B2 (ja) 2017-05-24

Family

ID=46829904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528537A Active JP6134319B2 (ja) 2011-09-01 2012-08-29 c−kitキナーゼインヒビターとしての化合物及び組成物

Country Status (30)

Country Link
US (3) US8569283B2 (https=)
EP (1) EP2751104B1 (https=)
JP (1) JP6134319B2 (https=)
KR (1) KR101962495B1 (https=)
CN (1) CN103797011B (https=)
AP (1) AP2014007493A0 (https=)
AR (1) AR087753A1 (https=)
AU (1) AU2012302042B2 (https=)
BR (1) BR112014004560A2 (https=)
CA (1) CA2845169C (https=)
CL (1) CL2014000492A1 (https=)
CO (1) CO6900141A2 (https=)
CR (1) CR20140107A (https=)
CU (1) CU20140024A7 (https=)
EA (1) EA026152B1 (https=)
ES (1) ES2761332T3 (https=)
GT (1) GT201400034A (https=)
IL (1) IL231227A0 (https=)
MA (1) MA35460B1 (https=)
MX (1) MX339937B (https=)
PE (1) PE20140909A1 (https=)
PH (1) PH12014500372A1 (https=)
PL (1) PL2751104T3 (https=)
PT (1) PT2751104T (https=)
SG (1) SG2014014369A (https=)
TN (1) TN2014000068A1 (https=)
TW (1) TW201313717A (https=)
UY (1) UY34301A (https=)
WO (1) WO2013033167A1 (https=)
ZA (1) ZA201401175B (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103797011B (zh) 2011-09-01 2016-03-30 诺华股份有限公司 作为c-Kit激酶抑制剂的化合物和组合物
US9199981B2 (en) * 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
EP3007689B1 (en) 2013-01-10 2018-03-07 Pulmokine, Inc. Non-selective kinase inhibitors
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
US9925184B2 (en) 2013-10-11 2018-03-27 Pulmokine, Inc. Spray-dry formulations
US20150288928A1 (en) * 2014-04-08 2015-10-08 Sony Corporation Security camera system use of object location tracking data
CN105384738B (zh) * 2014-08-21 2017-08-29 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
UA125171C2 (uk) 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
US10474987B2 (en) * 2015-08-05 2019-11-12 Whirlpool Corporation Object recognition system for an appliance and method for managing household inventory of consumables
US20190256509A1 (en) * 2016-06-08 2019-08-22 Chrysalis, Inc. Histone demethylase inhibitors
JP2019518046A (ja) 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
US20200308169A1 (en) 2016-06-16 2020-10-01 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacterials
AU2017329090B9 (en) 2016-09-19 2019-09-05 Novartis Ag Therapeutic combinations comprising a RAF inhibitor and a ERK inhibitor
RU2763525C2 (ru) 2016-10-27 2021-12-30 Пульмокин, Инк. Комбинированная терапия для лечения легочной гипертензии
US20180162291A1 (en) * 2016-12-12 2018-06-14 Wipro Limited System and method of dynamically adjusting field of view of an image capturing device
KR20190121315A (ko) 2017-03-01 2019-10-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 병용 요법
ES2952265T3 (es) 2017-05-02 2023-10-30 Novartis Ag Terapia combinada que comprende un inhibidor de Raf y trametinib
WO2019090088A1 (en) 2017-11-02 2019-05-09 Calico Life Sciences Llc Modulators of the integrated stress pathway
KR102625224B1 (ko) * 2018-10-31 2024-01-15 주식회사 큐로젠 피라졸-온 유도체를 유효성분으로 포함하는 자가면역질환의 예방, 개선 또는 치료용 조성물
US20220143049A1 (en) 2019-03-21 2022-05-12 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
MA55976A (fr) * 2019-05-13 2022-03-23 Novartis Ag Formes cristallines de n-(5-(5-((1r, 2s)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl) imidazo [1,2-a] pyridine-3-carboxamide
ES3025633T3 (en) 2019-05-13 2025-06-09 Novartis Ag New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
WO2021035788A1 (zh) 2019-08-29 2021-03-04 中国科学院合肥物质科学研究院 吡唑衍生物及其用途
US20220340564A1 (en) 2019-09-13 2022-10-27 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
TWI893032B (zh) 2019-12-13 2025-08-11 日商日本新藥股份有限公司 作為pdgf受體激酶抑制劑之化合物及組合物
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
JP2023534963A (ja) 2020-07-15 2023-08-15 サード ハーモニック バイオ, インコーポレイテッド 選択的c-kitキナーゼ阻害剤の結晶質形態
US11744823B2 (en) 2020-11-19 2023-09-05 Third Harmonic Bio, Inc. Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
MX2023010947A (es) 2021-03-16 2023-11-29 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
MX2023010941A (es) 2021-03-17 2023-11-28 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
CA3211592A1 (en) 2021-03-17 2022-09-22 Jerome Emile Georges Guillemont Antibacterial compounds
EP4423097A1 (en) 2021-10-28 2024-09-04 Janssen Sciences Ireland Unlimited Company Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
JP2025540958A (ja) * 2022-11-30 2025-12-17 ブループリント メディシンズ コーポレイション 蕁麻疹の治療のための野生型c-kitキナーゼ阻害剤としてのN-フェニル-ピラゾロ[1,5-A]ピリジン-3-カルボキサミド誘導体
WO2024123966A1 (en) * 2022-12-07 2024-06-13 Third Harmonic Bio, Inc. Compounds and compositions as c-kit kinase inhibitors
AU2023390239A1 (en) * 2022-12-07 2025-07-24 Third Harmonic Bio, Inc. Compounds and compositions as c-kit kinase inhibitors
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
WO2025072330A1 (en) * 2023-09-26 2025-04-03 Arcus Biosciences, Inc. Kit inhibitor compounds and methods of use thereof
WO2025256552A1 (zh) * 2024-06-11 2025-12-18 上海翰森生物医药科技有限公司 吡唑类衍生物抑制剂、其制备方法和应用
WO2025256609A1 (en) * 2024-06-13 2025-12-18 Third Harmonic Bio, Inc. Crystalline forms of a selective c-kit kinase inhibitor
WO2025259929A1 (en) * 2024-06-13 2025-12-18 Third Harmonic Bio, Inc. COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AU2003251561A1 (en) 2002-06-20 2004-01-06 Beacon Looms, Inc. Knitted electrical conductor fabric
UA94570C2 (en) 2004-09-09 2011-05-25 Натко Фарма Лимитед Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
WO2006071940A2 (en) 2004-12-23 2006-07-06 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US7754717B2 (en) * 2005-08-15 2010-07-13 Amgen Inc. Bis-aryl amide compounds and methods of use
WO2008058037A1 (en) * 2006-11-03 2008-05-15 Irm Llc Compounds and compositions as protein kinase inhibitors
AU2011329233A1 (en) * 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
US20130023751A1 (en) 2011-07-18 2013-01-24 Samuel Victor Lichtenstein Water retention monitoring
US20150051206A1 (en) 2011-09-01 2015-02-19 Irm Llc Compounds and compositions as c-kit kinase inhibitors
CN103797011B (zh) 2011-09-01 2016-03-30 诺华股份有限公司 作为c-Kit激酶抑制剂的化合物和组合物
KR20140105433A (ko) 2011-09-01 2014-09-01 아이알엠 엘엘씨 Pdgfr 키나제 억제제로서의 화합물 및 조성물
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2014525448A5 (https=)
ES2727376T3 (es) Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
CN113544130A (zh) 一种btk抑制剂环衍生物及其制备方法和药学上的应用
JP2019530667A (ja) ピリジル置換のインドール化合物
JP2019530667A5 (https=)
JP2015522002A5 (https=)
JP2024521618A (ja) 複素環式化合物
KR20190031585A (ko) Trka 키나제 저해제로서의 피롤리디닐 유레아 및 피롤리디닐 티오유레아 화합물
EP4284802A1 (en) Small molecule inhibitors of salt inducible kinases
AU2008267894A1 (en) Isoxazole-imidazole derivatives
RU2015144485A (ru) Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ
IL279266B2 (en) New isoxazolyl ether derivatives as gaba a alpha5 pam
EP4504719A1 (en) Egfr inhibitors
EP4149933A1 (en) New triazolyl derivatives as gaba a alpha5 pam
CN121712755A (zh) 吡啶基咪唑类化合物、其制备及其治疗用途
HK1233645A1 (en) Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds